| 2026-07-28 | Press release | Nautilus Biotechnology Reports Second Quarter 2026 Financial Results |
| 2026-07-08 | Press release | Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 SEATTLE, July 08, 2026 (GLOBE |
| 2026-04-28 | Press release | Nautilus Biotechnology Reports First Quarter 2026 Financial Results |
| 2026-04-09 | Press release | Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 |
| 2026-03-24 | Press release | Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference SEATTLE, March 24, 2026 (GLOBE NEW |
| 2026-03-18 | Press release | Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform |
| 2026-03-02 | Press release | Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales |
| 2026-02-26 | Press release | Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results SEATTLE, Feb. 26, 2026 (GLOBE NEWSW |
| 2026-02-24 | Press release | Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 |
| 2026-02-19 | Press release | Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference SEATTLE, Feb. 19, 2026 (GLOBE N |
| 2026-02-05 | Press release | Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 SEATTLE, Feb |
| 2026-01-28 | Press release | Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single |
| 2025-08-27 | Press release | Nautilus Biotechnology to Participate in Upcoming September Investor Conferences SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) |
| 2025-07-30 | Press release | Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule |
| 2025-05-27 | Press release | Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference SEATTLE, May 27, 202 |
| 2025-02-18 | Press release | Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference SEATTLE, Feb. 18, 2025 (GLOBE NE |
| Press release | Nautilus to Present at Goldman Sachs 42nd Annual Global Healthcare Conference SEATTLE–( BUSINESS WIRE )–Nautilus Biotech |